Methsuximide
- Product NDC
- 70954-228
- 11-digit product format
- 709540228
- Labeler code
- 70954
- Product ID
- 70954-228_5138e347-665b-4dd6-b9f8-12f4a807ed4e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methsuximide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA217213
- Marketing category
- ANDA
- Marketing start
- 2023-05-01
- Substance
- METHSUXIMIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methsuximide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHSUXIMIDE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0G76K8X6C0 |
| Rxcui | 197949 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70954-228-10 | Methsuximide | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70954-228 | METHSUXIMIDE CAPSULE [ANI PHARMACEUTICALS, INC.] | 1 | Current NDC, 1 package rows | 20230504_5138e347-665b-4dd6-b9f8-12f4a807ed4e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70954-228-10 | 70954022810 | 100 CAPSULE in 1 BOTTLE (70954-228-10) | 100 capsule | 2023-05-01 | No | No | Historical |